1 – 10 of 20
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Chronic intermittent L-DOPA treatment induces changes in dopamine release
(
- Contribution to journal › Article
-
Mark
3,4-dideoxyglucosone-3-ene in peritoneal dialysis fluids infused into the peritoneal cavity cannot be found in plasma.
2009) 12th Congress of the International-Society-for-Peritoneal-Dialysis In Peritoneal Dialysis International 29 Suppl 2. p.28-31(
- Contribution to journal › Article
- 2008
-
Mark
3,4-dge in peritoneal dialysis fluids cannot be found in plasma after infusion into the peritoneal cavity.
(
- Contribution to journal › Article
- 2007
-
Mark
Glucose degradation products in peritoneal dialysis fluids
2007)(
- Thesis › Doctoral thesis (compilation)
- 2006
-
Mark
3,7-dideacetyl-6 alpha-hydroxykhivorin, a new limonoid from Khaya senegalensis (Meliaceae)
(
- Contribution to journal › Article
-
Mark
Sex pheromone of the pine sawfly, Gilpinia pallida: Chemical identification, synthesis, and biological activity
(
- Contribution to journal › Article
-
Mark
How to avoid glucose degradation products in peritoneal dialysis fluids
(
- Contribution to journal › Article
- 2005
-
Mark
Take care in how you store your PD fluids: Actual temperature determines the balance between reactive and non-reactive GDPs
(
- Contribution to journal › Article
- 2004
-
Mark
PD fluids contain high concentrations of cytotoxic GDPs directly after sterilization
(
- Contribution to journal › Article
- 2002
-
Mark
3,4-Dideoxyglucosone-3-ene (3,4-DGE): A cytotoxic glucose degradation product in fluids for peritoneal dialysis
(
- Contribution to journal › Article